DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 33 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $906,000 | -88.6% | 203,641 | -76.6% | 0.49% | -83.3% |
| Q1 2021 | $7,963,000 | -2.7% | 870,228 | +7.8% | 2.93% | +50.5% |
| Q4 2020 | $8,182,000 | +164.4% | 806,900 | +10.5% | 1.95% | +24.2% |
| Q3 2020 | $3,095,000 | +121.9% | 730,000 | +262.7% | 1.57% | +73.6% |
| Q2 2020 | $1,395,000 | – | 201,248 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 233,730 | $369,293 | 0.45% |
| COOPERMAN LEON G | 812,508 | $1,283,844 | 0.08% |
| CATALYST FINANCIAL PARTNERS LLC | 14,475 | $22,872 | 0.01% |
| Legend Financial Advisors, Inc. | 1,000 | $1,580 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 184,870 | $292 | 0.00% |
| STATE STREET CORP | 133,258 | $210,548 | 0.00% |
| MORGAN STANLEY | 55,201 | $87,223 | 0.00% |
| BlackRock Inc. | 69,937 | $110,508 | 0.00% |
| Bank of New York Mellon Corp | 36,062 | $56,982 | 0.00% |
| Citadel Advisors | 1,600 | $2,528 | 0.00% |